Carlotta Buzzoni

Health Protection Agency — MV

Medicine · Health Sciences

35h-index10.0kcitations137works3.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Global Cancer Incidence and Screening(47), Colorectal Cancer Screening and Detection(26), Multiple and Secondary Primary Cancers(22), Cancer Risks and Factors(16), Acute Lymphoblastic Leukemia research(12)

Publications133 total

Cancer incidence, mortality, and survival estimates in Italy: Methodological approaches
Cancer Epidemiology·2025· 1 citedOpen Access
Emergency colon cancer diagnosis in people with mental health conditions: a population-based cohort study in northern Italy
BMJ Mental Health·2025· 5 citedOpen Access
Antenatal care services and pregnancy outcomes during the COVID-19 pandemic in Milan, Lombardy, Italy.
PubMed·2025
Comorbidities, Socioeconomic Status, and Colorectal Cancer Diagnostic Route
JAMA Network Open·2025· 18 citedOpen Access
Cancer Incidence, Mortality, and Survival Rates in Italy: Methodological Approaches
SSRN Electronic Journal·2025· 2 citedOpen Access
Quality of Data from Cancer Registries in Italy: An Appraisal
SSRN Electronic Journal·2025Open Access
Emergency Colon Cancer Diagnosis in People with Mental Disorders: A Population-Based Cohort Study in Northern Italy
SSRN Electronic Journal·2025Open Access
Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain
Future Oncology·2024· 1 citedOpen Access
Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn’s Disease in Italy
Advances in Therapy·2024· 6 citedOpen Access
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY)
Neurology and Therapy·2024· 3 citedOpen Access
Galcanezumab in the Treatment of Migraine: A Narrative Review of Real-World Studies
Clinical Neuropharmacology·2023· 1 cited
Description of characteristics, management of care and healthcare direct costs of patients with HR+/HER2- early breast cancer in Italy: a real-world study involving administrative and pathological anatomy databases
Expert Review of Pharmacoeconomics & Outcomes Research·2023· 3 cited
Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)
Journal of Dermatological Treatment·2023· 8 citedOpen Access
Patients with HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors: A Real-World Study in Italy
Breast Cancer Management·2023Open Access
POSC386 Patient Characteristics, Diagnostic Testing and Treatment Patterns in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (HR+, HER2-), Node-Positive, High-Risk Early Breast Cancer (EBC) in Italy: A Real-World Study
Value in Health·2022
Risk of thyroid as a first or second primary cancer. A population‐based study in Italy, 1998–2012
Cancer Medicine·2021· 18 citedOpen Access
RISK OF HEMOLYMPHOPOIETIC NEOPLASM BEFORE AND AFTER THYROID CANCER. A POPULATION‐BASED STUDY IN ITALY, 1998‐2012
Hematological Oncology·2021Open Access
[SENTIERI: Epidemiological Study of Residents in National Priority Contaminated Sites. Fifth Report].
PubMed·2020· 40 cited
Estimates of the incidence of infection-related cancers in Italy and Italian regions in 2018
PubMed·2019· 5 citedOpen Access
Epidemiology of Sinonasal Cancer
2019· 8 cited
page 1 of 7Next →

Frequent Co-authors

Emanuele Crocetti(28), Diego Serraino(27), Stefano Ferretti(25), Guido Mazzoleni(24), Roberta De Angelis(24), Adriano Giacomin(23), Annalisa Trama(22), Luigino Dal Maso(22), Silvia Francisci(21), Gemma Gatta(20), Laura Botta(20), Riccardo Capocaccia(20), Adele Caldarella(20), Milena Sant(19), Pamela Minicozzi(19), Daniela Pierannunzio(18), A. Bulatko(17), Paolo Baili(17), Sandra Mallone(17), Silvia Rossi(17)